Johnson_2012_Neurochem.Int_61_783

While acetylcholinesterase EC 3.1.1.7 has a clearly defined role in neurotransmission the functions of its sister enzyme butyrylcholinesterase EC 3.1.1.8 are more obscure. Numerous mutations many inactivating are observed in the human butyrylcholinesterase gene and the butyrylcholinesterase knockout mouse has an essentially normal phenotype suggesting that the enzyme may be redundant. Yet the gene has survived for many millions of years since the duplication of an ancestral acetylcholinesterase early in vertebrate evolution. In this paper we ask the questions why has butyrylcholinesterase been retained and why are inactivating mutations apparently tolerated Butyrylcholinesterase has diverged both structurally and in terms of tissue and cellular expression patterns from acetylcholinesterase Butyrylcholinesterase-like activity and enzymes have arisen a number of times in the animal kingdom suggesting the usefulness of such enzymes. Analysis of the published literature suggests that butyrylcholinesterase has specific roles in detoxification as well as in neurotransmission both in the brain where it appears to control certain areas and functions and in the neuromuscular junction where its function appears to complement that of acetylcholinesterase. An analysis of the mutations in human butyrylcholinesterase and their relation to the enzyme's structure is shown. In conclusion it appears that the structure of butyrylcholinesterase's catalytic apparatus is a compromise between the apparently conflicting selective demands of a more generalised detoxifier and the necessity for maintaining high catalytic efficiency It is also possible that the tolerance of mutation in human butyrylcholinesterase is a consequence of the detoxification function. Butyrylcholinesterase appears to be a good example of a gene that has survived by subfunctionalisation.